vs

Side-by-side financial comparison of CenterPoint Energy (CNP) and Edwards Lifesciences (EW). Click either name above to swap in a different company.

CenterPoint Energy is the larger business by last-quarter revenue ($2.4B vs $1.6B, roughly 1.5× Edwards Lifesciences). Edwards Lifesciences runs the higher net margin — 23.1% vs 10.8%, a 12.3% gap on every dollar of revenue. On growth, Edwards Lifesciences posted the faster year-over-year revenue change (16.7% vs 10.7%). Over the past eight quarters, Edwards Lifesciences's revenue compounded faster (9.7% CAGR vs -3.1%).

CenterPoint Energy, Inc. is an American utility company based in Houston, Texas, that provides electric and natural gas utility to customers in several markets in the American states of Indiana, Ohio, Louisiana, Minnesota, Mississippi, and Texas. Part of the Fortune 500, the company was formerly known as Reliant Energy, NorAm Energy, Houston Industries, and HL&P. The company is headquartered in the CenterPoint Energy Tower at 1111 Louisiana Street in Downtown Houston.

Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the Sapien transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via catheter.

CNP vs EW — Head-to-Head

Bigger by revenue
CNP
CNP
1.5× larger
CNP
$2.4B
$1.6B
EW
Growing faster (revenue YoY)
EW
EW
+6.0% gap
EW
16.7%
10.7%
CNP
Higher net margin
EW
EW
12.3% more per $
EW
23.1%
10.8%
CNP
Faster 2-yr revenue CAGR
EW
EW
Annualised
EW
9.7%
-3.1%
CNP

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CNP
CNP
EW
EW
Revenue
$2.4B
$1.6B
Net Profit
$264.0M
$380.7M
Gross Margin
78.0%
Operating Margin
22.2%
1.8%
Net Margin
10.8%
23.1%
Revenue YoY
10.7%
16.7%
Net Profit YoY
6.5%
6.8%
EPS (diluted)
$0.40
$0.66

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CNP
CNP
EW
EW
Q1 26
$1.6B
Q4 25
$2.4B
$1.6B
Q3 25
$2.0B
$1.6B
Q2 25
$2.0B
$1.5B
Q1 25
$3.0B
$1.4B
Q4 24
$2.2B
$1.4B
Q3 24
$1.8B
$1.4B
Q2 24
$1.9B
$1.4B
Net Profit
CNP
CNP
EW
EW
Q1 26
$380.7M
Q4 25
$264.0M
$91.2M
Q3 25
$293.0M
$291.1M
Q2 25
$198.0M
$333.2M
Q1 25
$297.0M
$358.0M
Q4 24
$248.0M
$385.6M
Q3 24
$193.0M
$3.1B
Q2 24
$228.0M
$366.3M
Gross Margin
CNP
CNP
EW
EW
Q1 26
78.0%
Q4 25
78.1%
Q3 25
99.9%
77.8%
Q2 25
99.9%
77.5%
Q1 25
100.0%
78.7%
Q4 24
100.0%
78.9%
Q3 24
99.9%
80.6%
Q2 24
79.9%
Operating Margin
CNP
CNP
EW
EW
Q1 26
1.8%
Q4 25
22.2%
9.6%
Q3 25
25.2%
19.8%
Q2 25
21.4%
26.8%
Q1 25
22.0%
27.9%
Q4 24
21.9%
22.6%
Q3 24
22.9%
25.9%
Q2 24
24.5%
26.8%
Net Margin
CNP
CNP
EW
EW
Q1 26
23.1%
Q4 25
10.8%
5.8%
Q3 25
14.7%
18.7%
Q2 25
10.1%
21.7%
Q1 25
10.0%
25.3%
Q4 24
11.3%
27.8%
Q3 24
10.4%
226.7%
Q2 24
12.0%
26.7%
EPS (diluted)
CNP
CNP
EW
EW
Q1 26
$0.66
Q4 25
$0.40
$0.16
Q3 25
$0.45
$0.50
Q2 25
$0.30
$0.56
Q1 25
$0.45
$0.61
Q4 24
$0.37
$0.65
Q3 24
$0.30
$5.13
Q2 24
$0.36
$0.61

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CNP
CNP
EW
EW
Cash + ST InvestmentsLiquidity on hand
$548.0M
Total DebtLower is stronger
$20.6B
Stockholders' EquityBook value
$11.2B
Total Assets
$46.5B
Debt / EquityLower = less leverage
1.84×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CNP
CNP
EW
EW
Q1 26
Q4 25
$548.0M
$4.2B
Q3 25
$616.0M
$3.8B
Q2 25
$776.0M
$4.1B
Q1 25
$1.9B
$3.9B
Q4 24
$585.0M
$4.0B
Q3 24
$643.0M
$4.4B
Q2 24
$543.0M
$2.0B
Total Debt
CNP
CNP
EW
EW
Q1 26
Q4 25
$20.6B
Q3 25
Q2 25
Q1 25
Q4 24
$20.4B
Q3 24
Q2 24
Stockholders' Equity
CNP
CNP
EW
EW
Q1 26
Q4 25
$11.2B
$10.3B
Q3 25
$11.0B
$10.2B
Q2 25
$11.0B
$10.5B
Q1 25
$11.0B
$10.1B
Q4 24
$10.7B
$10.0B
Q3 24
$10.5B
$9.5B
Q2 24
$10.4B
$7.4B
Total Assets
CNP
CNP
EW
EW
Q1 26
Q4 25
$46.5B
$13.7B
Q3 25
$45.0B
$13.3B
Q2 25
$44.1B
$13.5B
Q1 25
$44.5B
$13.0B
Q4 24
$43.8B
$13.1B
Q3 24
$42.9B
$13.0B
Q2 24
$41.0B
$10.1B
Debt / Equity
CNP
CNP
EW
EW
Q1 26
Q4 25
1.84×
Q3 25
Q2 25
Q1 25
Q4 24
1.91×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CNP
CNP
EW
EW
Operating Cash FlowLast quarter
$774.0M
Free Cash FlowOCF − Capex
$-707.0M
FCF MarginFCF / Revenue
-29.0%
Capex IntensityCapex / Revenue
60.7%
Cash ConversionOCF / Net Profit
2.93×
TTM Free Cash FlowTrailing 4 quarters
$-2.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CNP
CNP
EW
EW
Q1 26
Q4 25
$774.0M
$450.9M
Q3 25
$742.0M
$573.7M
Q2 25
$560.0M
$290.2M
Q1 25
$410.0M
$280.4M
Q4 24
$889.0M
$-127.5M
Q3 24
$136.0M
$351.8M
Q2 24
$576.0M
$371.5M
Free Cash Flow
CNP
CNP
EW
EW
Q1 26
Q4 25
$-707.0M
$353.5M
Q3 25
$-480.0M
$516.2M
Q2 25
$-569.0M
$240.9M
Q1 25
$-628.0M
$224.4M
Q4 24
$-1.1B
$-177.3M
Q3 24
$-708.0M
$299.9M
Q2 24
$-236.0M
$286.1M
FCF Margin
CNP
CNP
EW
EW
Q1 26
Q4 25
-29.0%
22.5%
Q3 25
-24.1%
33.2%
Q2 25
-29.1%
15.7%
Q1 25
-21.2%
15.9%
Q4 24
-51.0%
-12.8%
Q3 24
-38.3%
22.1%
Q2 24
-12.4%
20.9%
Capex Intensity
CNP
CNP
EW
EW
Q1 26
Q4 25
60.7%
6.2%
Q3 25
61.4%
3.7%
Q2 25
57.8%
3.2%
Q1 25
35.1%
4.0%
Q4 24
91.3%
3.6%
Q3 24
45.6%
3.8%
Q2 24
42.6%
6.2%
Cash Conversion
CNP
CNP
EW
EW
Q1 26
Q4 25
2.93×
4.94×
Q3 25
2.53×
1.97×
Q2 25
2.83×
0.87×
Q1 25
1.38×
0.78×
Q4 24
3.58×
-0.33×
Q3 24
0.70×
0.11×
Q2 24
2.53×
1.01×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CNP
CNP

Electric Segment$945.0M39%
Electric$890.0M37%
Other$603.0M25%

EW
EW

Segment breakdown not available.

Related Comparisons